BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36342719)

  • 1. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks.
    Black JC; Amioka E; Iwanicki JL; Dart RC; Monte AA
    JAMA Netw Open; 2022 Nov; 5(11):e2240526. PubMed ID: 36342719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic.
    Assaf RD; Gorbach PM; Cooper ZD
    Am J Drug Alcohol Abuse; 2022 May; 48(3):321-327. PubMed ID: 35130464
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States.
    Lake S; Assaf RD; Gorbach PM; Cooper ZD
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):174-183. PubMed ID: 35073161
    [No Abstract]   [Full Text] [Related]  

  • 4. The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States.
    Vidot DC; Islam JY; Marlene Camacho-Rivera ; Harrell MB; Rao DR; Chavez JV; Lucas G Ochoa ; Hlaing WM; Weiner M; Messiah SE
    J Addict Dis; 2021; 39(1):26-36. PubMed ID: 32933383
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal Cannabis Use Before and During the COVID-19 Pandemic.
    Minkoff HL; Ecker JL
    JAMA; 2022 Feb; 327(6):587. PubMed ID: 35133422
    [No Abstract]   [Full Text] [Related]  

  • 6. Prenatal Cannabis Use Before and During the COVID-19 Pandemic-Reply.
    Young-Wolff KC; Ansley D; Avalos LA
    JAMA; 2022 Feb; 327(6):587-588. PubMed ID: 35133418
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs.
    Bicket MC; Stone EM; McGinty EE
    JAMA Netw Open; 2023 Jan; 6(1):e2249797. PubMed ID: 36607641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States.
    Lake S; Assaf RD; Gorbach PM; Cooper ZD
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):482-490. PubMed ID: 35467920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to COVID-19 Pandemic: A Case Series.
    Mazza M; Caroppo E; Marano G; Kotzalidis GD; Avallone C; Camardese G; Janiri D; Moccia L; Simonetti A; Janiri L; Sani G
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in cannabis use among U.S. adults amid the COVID-19 pandemic.
    Brenneke SG; Nordeck CD; Riehm KE; Schmid I; Tormohlen KN; Smail EJ; Johnson RM; Kalb LG; Stuart EA; Thrul J
    Int J Drug Policy; 2022 Feb; 100():103517. PubMed ID: 34894469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020.
    Assaf RD; Hamad R; Javanbakht M; Arah OA; Shoptaw SJ; Cooper ZD; Gorbach PM
    Harm Reduct J; 2024 Apr; 21(1):82. PubMed ID: 38622670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review.
    Bonnet U; Specka M; Roser P; Scherbaum N
    J Neural Transm (Vienna); 2023 Jan; 130(1):7-18. PubMed ID: 36346483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anonymized location data reveals trends in legal Cannabis use in communities with increased mental health risks at the start of the COVID-19 pandemic.
    Ashby NJS
    J Addict Dis; 2021; 39(4):436-440. PubMed ID: 33595413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020.
    Imtiaz S; Wells S; Rehm J; Wickens CM; Hamilton H; Nigatu YT; Jankowicz D; Elton-Marshall T
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):14. PubMed ID: 35189909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closing the Loophole on Hemp-Derived Cannabis Products: A Public Health Priority.
    Harlow AF; Leventhal AM; Barrington-Trimis JL
    JAMA; 2022 Nov; 328(20):2007-2008. PubMed ID: 36331491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in cannabis use among adults with children in the home in the United States, 2004-2017: impact of state-level legalization for recreational and medical use.
    Goodwin RD; Kim JH; Cheslack-Postava K; Weinberger AH; Wu M; Wyka K; Kattan M
    Addiction; 2021 Oct; 116(10):2770-2778. PubMed ID: 33730400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and Safety in the Legal Cannabis Industry Before and During COVID-19.
    Otañez M; Grewal J
    New Solut; 2021 Feb; 30(4):311-323. PubMed ID: 33256503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Retail Sales of Alcohol and Cannabis During the COVID-19 Pandemic in Canada.
    MacKillop J; Cooper A; Costello J
    JAMA Netw Open; 2021 Nov; 4(11):e2133076. PubMed ID: 34735016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.